Evaluation of Infective Endocarditis in Children: A 19-Year Retrospective Study in Taiwan
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Definitions
2.3. Statistical Analysis
3. Results
3.1. Clinical Features and Major Outcomes
3.2. Clinical Characteristics of the Subgroups
3.3. Risk Factors for In-Hospital Mortality
4. Discussion
5. Limitations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A. ICD Diagnosis or NHI Procedure Codes for Study
Inclusion | ICD Diagnosis Codes or NHI Procedure Codes |
Congenital heart disease (CHD) | |
Atrial septal defect (ASD) | 7455, Q211 |
Patent ductus arteriosus (PDA) | 7470, Q250 |
Ventricular septal defect (VSD) | 7454, Q210 |
Endocardial cushion defects (ECD) | 7456, 74560, 74561, 74569, Q212 |
Aortic arch anomaly | 7471, 74710, 74711, 7472, 74720, 74721, 74722, 74729, Q251.x, Q252.x, Q253.x, Q254.x |
Cyanotic congenital heart disease (cyanotic CHD) | |
Teratology of Fallot/DORV/pulmonary atresia | 7452, 74511, 74601, Q201, Q213, Q220 |
Transposition of the great arteries or congenitally corrected transposition of the great arteries | 7451, 74510, 74512, 74519, Q203, |
Common truncus/Aortopulmonary septal defect | 7450, Q200, Q214 |
Single ventricle physiology | 7453, 7461, 7467, Q202, Q204, Q226, Q234 |
Pulmonary HTN (Pul HTN) | 4160, 4168, 4169, I270, I272 |
Hypertrophic cardiomyopathy (HCM) | 4251, I421, I422, I424 |
Marfan syndrome | 75982, Q874 |
Rheumatic heart disease (RHD) | 390, 391, 3918, 3919, 3920, 3929, 3941, 3971, 398, 3989, 39890, 39891, 39899, I00, I01, I018, I019, I020, I029, I050, I051, I052, I058, I059, I080, I081, I082, I083, I09, I098, I0981, I0989, I099 |
Valve involved | |
Mitral valve | 7465, 7466, 394, 3940, 3942, 3949, 4240, I34, I340, I341, I342, I348, I349, Q232, Q233 |
Aortic valve | 7463, 7464, 74681, 7471, 74710, 74711, 7472, 74720, 74721, 74722, 74729, Q230, Q231, Q251, Q252, Q253, Q244, I35, I350, I351, I352, I358, I359 |
Aortic and mitral valves | 396, 3960, 3961, 3962, 3963, 3968, 3969, Q23, Q238, Q239 |
Pulmonic valve | 4243, 7460, 74600, 74601, 74602, 74609, 74683, I370, I371, I372, I378, I379, Q220, Q221, Q222, Q223, Q243 |
Tricuspid valve | 7461, 7462, 4242, 7462, I36, I360, I361, I362, I368, I369, Q224, Q225, Q228, Q229 |
Prosthetic valve | 99671, V433 (ICD-9); Z952, T820.x, T8222.x |
Complications | |
Neurologic | 433.x, 434.x, or 436, I63, I65, I66, 431 or 432, I60, I61, I62, |
Cardiac | 428.x, I50; 410.x, I21, I22, I23, I24; 427.1, 427.4, 427.41, or 427.42, I472, I490 |
Pulmonary embolism | 415, I26 |
Valve surgery | 68015B, 68016B, 68017B, 68018B, 68029B |
References
- Ferrieri, P.; Gewitz, M.H.; Gerber, M.A.; Newburger, J.W.; Dajani, A.S.; Shulman, S.T.; Wilson, W.; Bolger, A.F.; Bayer, A.; Levison, M.E.; et al. Unique features of infective endocarditis in childhood. Circulation 2002, 105, 2115–2126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cahill, T.J.; Prendergast, B.D. Infective endocarditis. Lancet 2016, 387, 882–893. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martin, J.M.; Neches, W.H.; Wald, E.R. Infective endocarditis: 35 years of experience at a children’s hospital. Clin. Infect. Dis. 1997, 24, 669–675. [Google Scholar] [CrossRef] [Green Version]
- Morris, C.D.; Reller, M.D.; Menashe, V.D. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 1998, 279, 599–603. [Google Scholar] [CrossRef] [Green Version]
- Shao, S.C.; Chan, Y.Y.; Kao Yang, Y.H.; Lin, S.J.; Hung, M.J.; Chien, R.N.; Lai, C.; Lai, E.C. The Chang Gung Research Database—A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol. Drug Saf. 2019, 28, 593–600. [Google Scholar] [CrossRef]
- Rushani, D.; Kaufman, J.S.; Ionescu-Ittu, R.; Mackie, A.S.; Pilote, L.; Therrien, J.; Marelli, A.J. Infective endocarditis in children with congenital heart disease: Cumulative incidence and predictors. Circulation 2013, 128, 1412–1419. [Google Scholar] [CrossRef] [Green Version]
- Habib, G.; Badano, L.; Tribouilloy, C.; Vilacosta, I.; Zamorano, J.L.; Galderisi, M.; Voigt, J.-U.; Sicari, R.; Cosyns, B.; Fox, K.; et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur. J. Echocardiogr. 2010, 11, 202–219. [Google Scholar] [CrossRef] [Green Version]
- Lytzen, R.; Vejlstrup, N.; Bjerre, J.; Petersen, O.B.; Leenskjold, S.; Dodd, J.K.; Jørgensen, F.S.; Søndergaard, L. Live-Born Major Congenital Heart Disease in Denmark: Incidence, Detection Rate, and Termination of Pregnancy Rate From 1996 to 2013. JAMA Cardiol. 2018, 3, 829–837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, C.Y.; Wang, Y.C.; Yang, Y.S.; Chang, C.Y.; Chen, K.Y.; Lai, J.J.; Lin, J.-C.; Chang, F.-Y. Microbiological features, clinical characteristics and outcomes of infective endocarditis in adults with and without hemodialysis: A 10-year retrospective study in Northern Taiwan. J. Microbiol. Immunol. Infect. 2020, 53, 336–343. [Google Scholar] [CrossRef]
- Brouqui, P.; Raoult, D. Endocarditis due to rare and fastidious bacteria. Clin. Microbiol. Rev. 2001, 14, 177–207. [Google Scholar] [CrossRef] [Green Version]
- Raoult, D.; Casalta, J.P.; Richet, H.; Khan, M.; Bernit, E.; Rovery, C.; Branger, S.; Gouriet, F.; Imbert, G.; Bothello, E.; et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J. Clin. Microbiol. 2005, 43, 5238–5242. [Google Scholar] [CrossRef] [Green Version]
- Lamas, C.C.; Fournier, P.E.; Zappa, M.; Brandao, T.J.; Januario-da-Silva, C.A.; Correia, M.G.; Barbosa, G.I.F.; Golebiovski, W.F.; Weksler, C.; Lepidi, H.; et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection 2016, 44, 459–466. [Google Scholar] [CrossRef] [PubMed]
- Tattevin, P.; Watt, G.; Revest, M.; Arvieux, C.; Fournier, P.E. Update on blood culture-negative endocarditis. Med. Mal. Infect. 2015, 45, 1–8. [Google Scholar] [CrossRef]
- Habib, G.; Lancellotti, P.; Antunes, M.J.; Bongiorni, M.G.; Casalta, J.P.; Del Zotti, F.; Dulgheru, R.; El Khoury, G.; Erba, P.A.; Iung, B.; et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J. 2015, 36, 3075–3128. [Google Scholar]
- El-Ashry, A.H.; Saad, K.; Obiedallah, A.A.; Elhoufey, A.; Dailah, H.G.; Hussein, M.S.A. Molecular and Serological Diagnostic Approach to Define the Microbiological Origin of Blood Culture-Negative Infective Endocarditis. Pathogens 2022, 11, 1220. [Google Scholar] [CrossRef] [PubMed]
- Garg, N.; Kandpal, B.; Garg, N.; Tewari, S.; Kapoor, A.; Goel, P.; Sinha, N. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. Int. J. Cardiol. 2005, 98, 253–260. [Google Scholar] [CrossRef] [PubMed]
- Topan, A.; Carstina, D.; Slavcovici, A.; Rancea, R.; Capalneanu, R.; Lupse, M. Assesment of the Duke criteria for the diagnosis of infective endocarditis after twenty-years. An analysis of 241 cases. Med. Pharm. Rep. 2015, 88, 321–326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tariq, M.; Alam, M.; Munir, G.; Khan, M.A.; Smego, R.A., Jr. Infective endocarditis: A five-year experience at a tertiary care hospital in Pakistan. Int. J. Infect. Dis. 2004, 8, 163–170. [Google Scholar] [CrossRef] [Green Version]
- Zamorano, J.; Sanz, J.; Moreno, R.; Almeria, C.; Rodrigo, J.L.; Samedi, M.; Herrera, D.; Aubele, A.; Mataix, L.; Serra, V.; et al. Comparison of outcome in patients with culture-negative versus culture-positive active infective endocarditis. Am. J. Cardiol. 2001, 87, 1423–1425. [Google Scholar] [CrossRef]
- Fournier, P.E.; Gouriet, F.; Casalta, J.P.; Lepidi, H.; Chaudet, H.; Thuny, F.; Collart, F.; Habib, G.; Raoult, D. Blood culture-negative endocarditis: Improving the diagnostic yield using new diagnostic tools. Medicine 2017, 96, e8392. [Google Scholar] [CrossRef]
- Mulder, B.J. Endocarditis in congenital heart disease: Who is at highest risk? Circulation 2013, 128, 1396–1397. [Google Scholar] [CrossRef] [Green Version]
- Day, M.D.; Gauvreau, K.; Shulman, S.; Newburger, J.W. Characteristics of children hospitalized with infective endocarditis. Circulation 2009, 119, 865–870. [Google Scholar] [CrossRef] [Green Version]
- Tutarel, O.; Alonso-Gonzalez, R.; Montanaro, C.; Schiff, R.; Uribarri, A.; Kempny, A.; Grübler, M.R.; Uebing, A.; Swan, L.; Diller, G.-P.; et al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart 2018, 104, 161–165. [Google Scholar] [CrossRef] [PubMed]
- Knirsch, W.; Haas, N.A.; Uhlemann, F.; Dietz, K.; Lange, P.E. Clinical course and complications of infective endocarditis in patients growing up with congenital heart disease. Int. J. Cardiol. 2005, 101, 285–291. [Google Scholar] [CrossRef]
- Tleyjeh, I.M.; Steckelberg, J.M.; Murad, H.S.; Anavekar, N.S.; Ghomrawi, H.M.; Mirzoyev, Z.; Moustafa, S.E.; Hoskin, T.L.; Mandrekar, J.N.; Wilson, W.R.; et al. Temporal trends in infective endocarditis: A population-based study in Olmsted County, Minnesota. JAMA 2005, 293, 3022–3028. [Google Scholar] [CrossRef] [Green Version]
- Mylonakis, E.; Calderwood, S.B. Infective endocarditis in adults. N. Engl. J. Med. 2001, 345, 1318–1330. [Google Scholar] [CrossRef]
- Verheugt, C.L.; Uiterwaal, C.S.; van der Velde, E.T.; Meijboom, F.J.; Pieper, P.G.; Veen, G.; Stappers, J.L.; Grobbee, D.E.; Mulder, B.J. Turning 18 with congenital heart disease: Prediction of infective endocarditis based on a large population. Eur. Heart J. 2011, 32, 1926–1934. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coward, K.; Tucker, N.; Darville, T. Infective endocarditis in Arkansan children from 1990 through 2002. Pediatr. Infect. Dis. J. 2003, 22, 1048–1052. [Google Scholar] [CrossRef]
- Slipczuk, L.; Codolosa, J.N.; Davila, C.D.; Romero-Corral, A.; Yun, J.; Pressman, G.S.; Figueredo, V.M. Infective endocarditis epidemiology over five decades: A systematic review. PLoS ONE 2013, 8, e82665. [Google Scholar] [CrossRef]
- McKinsey, D.S.; Ratts, T.E.; Bisno, A.L. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am. J. Med. 1987, 82, 681–688. [Google Scholar] [CrossRef] [PubMed]
- Castillo, J.C.; Anguita, M.P.; Torres, F.; Siles, J.R.; Mesa, D.; Valles, F. Risk factors associated with endocarditis without underlying heart disease. Rev. Esp. Cardiol. 2002, 55, 304–307. [Google Scholar] [CrossRef] [PubMed]
- Saiman, L.; Prince, A.; Gersony, W.M. Pediatric infective endocarditis in the modern era. J. Pediatr. 1993, 122, 847–853. [Google Scholar] [CrossRef]
- Tolan, R.W., Jr.; Kleiman, M.B.; Frank, M.; King, H.; Brown, J.W. Operative intervention in active endocarditis in children: Report of a series of cases and review. Clin. Infect. Dis. 1992, 14, 852–862. [Google Scholar] [CrossRef] [PubMed]
- Ferrera, C.; Vilacosta, I.; Fernandez, C.; Lopez, J.; Sarria, C.; Olmos, C.; Vivas, D.; Sáez, C.; Sánchez-Enrique, C.; Ortiz, C.; et al. Usefulness of thrombocytopenia at admission as a prognostic marker in native valve left-sided infective endocarditis. Am. J. Cardiol. 2015, 115, 950–955. [Google Scholar] [CrossRef]
- Sy, R.W.; Chawantanpipat, C.; Richmond, D.R.; Kritharides, L. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur. Heart J. 2011, 32, 2016–2026. [Google Scholar] [CrossRef] [Green Version]
- Sy, R.W.; Chawantanpipat, C.; Richmond, D.R.; Kritharides, L. Thrombocytopenia and mortality in infective endocarditis. J. Am. Coll. Cardiol. 2008, 51, 1824–1825. [Google Scholar] [CrossRef] [Green Version]
- Levy, M.M.; Fink, M.P.; Marshall, J.C.; Abraham, E.; Angus, D.; Cook, D.; Cohen, J.; Opal, S.M.; Vincent, J.-L.; Ramsay, G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003, 29, 530–538. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, F.L.; Bota, D.P.; Bross, A.; Melot, C.; Vincent, J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286, 1754–1758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marshall, J.C.; Cook, D.J.; Christou, N.V.; Bernard, G.R.; Sprung, C.L.; Sibbald, W.J. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 1995, 23, 1638–1652. [Google Scholar] [CrossRef]
- San Roman, J.A.; Lopez, J.; Vilacosta, I.; Luaces, M.; Sarria, C.; Revilla, A.; Ronderos, R.; Stoermann, W.; Gómez, I.; Fernández-Avilés, F. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am. J. Med. 2007, 120, e1–e7. [Google Scholar] [CrossRef]
- Deppermann, C.; Kubes, P. Start a fire, kill the bug: The role of platelets in inflammation and infection. Innate Immun. 2018, 24, 335–348. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sullam, P.M.; Frank, U.; Yeaman, M.R.; Tauber, M.G.; Bayer, A.S.; Chambers, H.F. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect. Dis. 1993, 168, 910–914. [Google Scholar] [CrossRef] [PubMed]
- Levi, M. Platelets in sepsis. Hematology 2005, 10 (Suppl. S1), 129–131. [Google Scholar] [CrossRef]
- Dall, L.; Miller, T.; Herndon, B.; Diez, I.; Dew, M. Platelet depletion and severity of streptococcal endocarditis. Can. J. Infect. Dis. 1998, 9, 359–366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
N (n (%)) | Age (Median (IQR)) | |
---|---|---|
Patient, n | 208 | 13 (4, 18) |
Sex, n (%) | ||
Male | 118 (56.7) | 13 (3, 18) |
Female | 90 (43.3) | 14 (6–19) |
CHD | 40 (19.2) | 7 (2, 15) |
ASD | 1 (0.5) | 5 |
PDA | 3 (1.4) | 17 (3, 19) |
VSD | 28 (13.5) | 9 (3, 15) |
ECD | 7 (3.4) | 1 (0, 8) |
Ao arch | 9 (4.3) | 6 (1, 12) |
Cyanotic CHD | 26 (12.5) | 4 (0, 15) |
Pul HTN | 10 (4.8) | 14 (4, 15) |
HCM | 3 (1.4) | 10 (3, 18) |
Marfan | 1 (0.5) | 15 |
RHD | 6 (2.9) | 17 (12, 19) |
Valve involved | ||
Mitral | 48 (23.1) | 17 (14, 19) |
Aortic | 16 (7.7) | 13 (8, 17) |
Mitral and aortic | 3 (1.4) | 9 (8, 19) |
Pulmonary | 19 (9.1) | 4 (0, 12) |
Tricuspid | 8 (3.8) | 15 (9, 16) |
Prosthetic valve | 4 (1.9) | 13 (10, 18) |
Complications | ||
Neurologic | 13 (6.3) | 17 (14, 19) |
Cardiac | 40 (19.2) | 13 (3, 18) |
Pulmonary embolism | 15 (7.2) | 15 (8, 20) |
Valve surgery | 58 (27.9) | 14 (5, 19) |
Mortality | 14 (6.7) | 9 (0, 19) |
Characteristics | Overall (n = 208) | Heart Disease 1 (n = 114) | Non-Heart Disease (n = 94) | p-Value |
---|---|---|---|---|
GENERAL | ||||
Age, y (median [IQR]) | 13 (4, 18) | 13 (4, 18) | 11.5 (4, 18) | 0.7671 |
Male, n (%) | 118 (56.7) | 66 (57.9) | 52 (55.3) | 0.7091 |
MICROBIOLOGY | 58 (27.9) | 37 (32.5) | 21 (22.3) | 0.1054 |
Streptococci, n (%) | 24 (11.5) | 22 (19.3) | 2 (2.1) | 0.0001 |
Staphylococci, n (%) | 33 (15.9) | 16 (14.0) | 17 (18.1) | 0.4262 |
Staphylococcus aureus, n (%) | 27 (13.0) | 14 (12.3) | 13 (13.8) | 0.7408 |
Pseudomonas, n (%) | 2 (1.0) | 0 (0) | 2 (2.1) | 0.203 |
Candida, n (%) | 2 (1.0) | 0 (0) | 2 (2.1) | 0.203 |
COMPLICATIONS | 60 (28.9) | 45 (39.5) | 15 (16) | 0.0002 |
Neurologic 2, n (%) | 13 (6.3) | 10 (8.8) | 3 (3.2) | 0.098 |
Cardiac 3, n (%) | 40 (19.2) | 34 (29.8) | 6 (6.4) | <0.0001 |
PE, n (%) | 15 (7.2) | 8 (7.0) | 7 (7.4) | 0.9052 |
VALVE SURGERY, n (%) | 58 (27.9) | 50 (43.9) | 8 (8.5) | <0.0001 |
MORTALITY, n (%) | 14 (6.7) | 4 (3.5) | 10 (10.6) | 0.0411 |
Hospital stay (median (IQR)) | 20 (6, 40.5) | 28.5 (8.25, 42.75) | 12.5 (5, 36.75) | 0.021 |
Risk Factors | Overall (n = 166) | Recovered (n = 154) | Died (n = 12) | p-Value | Univariable Analysis | Multivariable Analysis |
---|---|---|---|---|---|---|
OR (95% CI 6) | aOR (95% CI) | |||||
Age (median [IQR]) | 13.19 [4.78, 18.67] | 13.19 [4.95, 18.72] | 8.91 [0.26, 18.36] | 0.201 | 0.96 (0.88–1.04) | 0.92 (0.83–1.01) |
Male, n (%) | 76 (45.8) | 70 (45.5) | 6 (50.0) | 0.773 | 1.2 (0.36–4.00) | 1.32 (0.36–4.9) |
Heart disease 1, n (%) | 91 (54.8) | 87 (56.5) | 4 (33.3) | 0.141 | 0.41 (0.11–1.29) | 0.5 (0.12–1.8) |
Microbiology, n (%) | 57 (34.3) | 53 (34.4) | 4 (33.3) | 1 | 1 (0.28–3.19) | - 7 |
Leukocytosis, n (%) | 114 (68.7) | 104 (67.5) | 10 (83.3) | 0.344 | 2.03 (0.56–10.82) | - |
Left shift, n (%) | 39 (23.5) | 31 (20.1) | 8 (66.7) | 0.001 | 7.41 (2.29–27.17) | 2.98 (0.78–12.67) |
Anemia, n (%) | 131 (78.9) | 121 (78.6) | 10 (83.3) | 1 | 1.16 (0.32–6.22) | - |
Thrombocytopenia, n (%) | 55 (33.1) | 45 (29.2) | 10 (83.3) | <0.001 | 10.11 (2.79–53.99) | 6.56 (1.43–40.37) |
Neurologic complications 2, n (%) | 12 (7.2) | 10 (6.5) | 2 (16.7) | 0.464 | 3.28 (0.58–13.45) | 3.52 (0.49–19.71) |
Cardiac complications 3, n (%) | 36 (21.7) | 34 (22.1) | 2 (16.7) | 0.941 | 0.83 (0.15–3.05) | - |
Pulmonary embolism, n (%) | 12 (7.2) | 12 (7.8) | 0 (0.0) | 0.671 | 0.46 (0–3.86) | - |
Lt-sided valve 4 | 51 (30.7) | 49 (31.8) | 2 (16.7) | 0.441 | 0.51 (0.1–1.84) | - |
Rt-sided valve 5 | 20 (12.0) | 18 (11.7) | 2 (16.7) | 0.96 | 1.76 (0.32–6.72) | - |
Valve surgery, n (%) | 52 (31.3) | 50 (32.5) | 2 (16.7) | 0.416 | 0.49 (0.09–1.78) | - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chien, S.-J.; Tseng, Y.-J.; Huang, Y.-H.; Liu, H.-Y.; Wu, Y.-H.; Chang, L.-S.; Yang, Y.-H.; Lin, Y.-J. Evaluation of Infective Endocarditis in Children: A 19-Year Retrospective Study in Taiwan. J. Clin. Med. 2023, 12, 2298. https://doi.org/10.3390/jcm12062298
Chien S-J, Tseng Y-J, Huang Y-H, Liu H-Y, Wu Y-H, Chang L-S, Yang Y-H, Lin Y-J. Evaluation of Infective Endocarditis in Children: A 19-Year Retrospective Study in Taiwan. Journal of Clinical Medicine. 2023; 12(6):2298. https://doi.org/10.3390/jcm12062298
Chicago/Turabian StyleChien, Shao-Ju, Yi-Ju Tseng, Ying-Hua Huang, Hsi-Yun Liu, Yi-Hua Wu, Ling-Sai Chang, Yao-Hsu Yang, and Ying-Jui Lin. 2023. "Evaluation of Infective Endocarditis in Children: A 19-Year Retrospective Study in Taiwan" Journal of Clinical Medicine 12, no. 6: 2298. https://doi.org/10.3390/jcm12062298
APA StyleChien, S.-J., Tseng, Y.-J., Huang, Y.-H., Liu, H.-Y., Wu, Y.-H., Chang, L.-S., Yang, Y.-H., & Lin, Y.-J. (2023). Evaluation of Infective Endocarditis in Children: A 19-Year Retrospective Study in Taiwan. Journal of Clinical Medicine, 12(6), 2298. https://doi.org/10.3390/jcm12062298